ATE297887T1 - Nervonsäurederivate,ihre herstellung und anwendung - Google Patents

Nervonsäurederivate,ihre herstellung und anwendung

Info

Publication number
ATE297887T1
ATE297887T1 AT00977695T AT00977695T ATE297887T1 AT E297887 T1 ATE297887 T1 AT E297887T1 AT 00977695 T AT00977695 T AT 00977695T AT 00977695 T AT00977695 T AT 00977695T AT E297887 T1 ATE297887 T1 AT E297887T1
Authority
AT
Austria
Prior art keywords
acid derivatives
production
nervoic
those compounds
nervoic acid
Prior art date
Application number
AT00977695T
Other languages
English (en)
Inventor
Keith Coupland
Yann Raoul
Original Assignee
Croda Int Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Croda Int Plc filed Critical Croda Int Plc
Application granted granted Critical
Publication of ATE297887T1 publication Critical patent/ATE297887T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/52—Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/533—Monocarboxylic acid esters having only one carbon-to-carbon double bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/231—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/52—Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/587—Monocarboxylic acid esters having at least two carbon-to-carbon double bonds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT00977695T 1999-11-24 2000-11-23 Nervonsäurederivate,ihre herstellung und anwendung ATE297887T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9927629.7A GB9927629D0 (en) 1999-11-24 1999-11-24 Compounds
PCT/GB2000/004453 WO2001038288A1 (en) 1999-11-24 2000-11-23 Nervonic acid derivatives, their preparation and use

Publications (1)

Publication Number Publication Date
ATE297887T1 true ATE297887T1 (de) 2005-07-15

Family

ID=10864957

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00977695T ATE297887T1 (de) 1999-11-24 2000-11-23 Nervonsäurederivate,ihre herstellung und anwendung

Country Status (11)

Country Link
US (1) US6664406B1 (de)
EP (1) EP1232139B1 (de)
JP (1) JP3993434B2 (de)
AT (1) ATE297887T1 (de)
AU (1) AU775643B2 (de)
CA (1) CA2391953C (de)
DE (1) DE60020873T2 (de)
ES (1) ES2242651T3 (de)
GB (2) GB9927629D0 (de)
NZ (1) NZ518961A (de)
WO (1) WO2001038288A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0112324D0 (en) * 2001-05-21 2001-07-11 Croda Int Plc Compounds
WO2004084829A2 (en) * 2003-03-20 2004-10-07 Imagenetix, Inc. Esterified fatty acid composition
US20070149618A1 (en) * 2004-02-17 2007-06-28 Action Medicines, S.L. Methods of use for 2,5-dihydroxybenzene sulfonic acid compounds for the treatment of cancer, rosacea and psoriasis
US20080125485A1 (en) 2004-02-17 2008-05-29 Action Medicines Use of 2,5-Dihydroxybenzene Derivatives for Treating Actinic Keratosis
ES2238924B1 (es) * 2004-02-17 2006-12-01 Investread Europa, S.L. Uso del acido 2,5-dihidroxibencenosulfonico, en la fabricacion de medicamentos de aplicacion en el tratamiento de enfermedades angiodependientes.
US7776914B2 (en) 2004-03-22 2010-08-17 Imagenetix, Inc. Esterified fatty acid composition
PT2054051E (pt) 2006-08-16 2013-04-03 Amderma Pharmaceuticals Llc Utilização de derivados 2,5-di-hidroxibenzeno para tratar ceratose actínica
ES2491226T3 (es) 2006-08-16 2014-09-05 AmDerma Pharmaceuticals, LLC Compuestos de 2,5-dihidroxibenceno para el tratamiento de psoriaris
US8269062B2 (en) 2006-11-21 2012-09-18 National Research Council Of Canada Lunaria annua, Cardamine graeca and Teesdalia nudicaulis FAE genes and their use in producing nervonic and eicosenoic acids in seed oils
FR2940281B1 (fr) 2008-12-22 2011-04-01 Fabre Pierre Dermo Cosmetique Ester de diol et d'acide gras polyinsature comme agent anti-acne
CA2793959C (en) 2010-03-25 2019-06-04 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
PL2691530T3 (pl) 2011-06-10 2019-02-28 Oregon Health & Science University Glikoproteiny i rekombinowane wektory CMV
EP2739410B1 (de) 2011-08-05 2023-03-29 Massachusetts Institute of Technology Gegenstand mit einer flüssigkeitsimprägnierten oberfläche
JP5803424B2 (ja) * 2011-08-22 2015-11-04 Jnc株式会社 ビニル酢酸の製造方法、ビニル酢酸誘導体及びその製造方法
EP2568289A3 (de) 2011-09-12 2013-04-03 International AIDS Vaccine Initiative Immunselektion von rekombinantem vesikulärem Stomatitisvirus mit Expression von HIV-1-Proteinen durch Breitbandneutralisierungs-Antikörper
EP2586461A1 (de) 2011-10-27 2013-05-01 Christopher L. Parks Von einem eingehüllten Virus abgeleitete Virenpartikel
JP2015510857A (ja) 2012-03-23 2015-04-13 マサチューセッツ インスティテュート オブ テクノロジー 食品包装および食品加工装置のための自己潤滑性表面
US9625075B2 (en) 2012-05-24 2017-04-18 Massachusetts Institute Of Technology Apparatus with a liquid-impregnated surface to facilitate material conveyance
US20130337027A1 (en) 2012-05-24 2013-12-19 Massachusetts Institute Of Technology Medical Devices and Implements with Liquid-Impregnated Surfaces
EP2679596B1 (de) 2012-06-27 2017-04-12 International Aids Vaccine Initiative HIV-1 Env-proteinvariante
CN109719109B (zh) 2012-11-19 2023-01-06 麻省理工学院 采用液体浸渍表面的装置和方法
US20140178611A1 (en) 2012-11-19 2014-06-26 Massachusetts Institute Of Technology Apparatus and methods employing liquid-impregnated surfaces
US20150065381A1 (en) 2013-09-05 2015-03-05 International Aids Vaccine Initiative Methods of identifying novel hiv-1 immunogens
US10058604B2 (en) 2013-10-07 2018-08-28 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
US9947481B2 (en) 2014-06-19 2018-04-17 Massachusetts Institute Of Technology Lubricant-impregnated surfaces for electrochemical applications, and devices and systems using same
EP3069730A3 (de) 2015-03-20 2017-03-15 International Aids Vaccine Initiative Lösliche hiv-1-hüllglykoproteintrimere
EP3072901A1 (de) 2015-03-23 2016-09-28 International Aids Vaccine Initiative Lösliche hiv-1-hüllglykoproteintrimere
CN115466178A (zh) * 2021-06-11 2022-12-13 青岛海合生物科技有限公司 一种神经酸衍生物及其制备方法和应用
CN113495161B (zh) * 2021-09-07 2021-11-16 宝枫生物科技（北京）有限公司 用于诊断缺血缺氧性脑病补充神经酸起效的生物标志物及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE135208T1 (de) 1989-11-30 1996-03-15 Croda Int Plc Verwendung von nervonsäure und langkettiger fettsäuren zur behandlung demyelinisierender erkrankungen
MY118354A (en) 1995-05-01 2004-10-30 Scarista Ltd 1,3-propane diol derivatives as bioactive compounds

Also Published As

Publication number Publication date
EP1232139B1 (de) 2005-06-15
GB0028525D0 (en) 2001-01-10
CA2391953A1 (en) 2001-05-31
AU1533301A (en) 2001-06-04
GB2357083A (en) 2001-06-13
ES2242651T3 (es) 2005-11-16
US6664406B1 (en) 2003-12-16
JP3993434B2 (ja) 2007-10-17
NZ518961A (en) 2004-02-27
AU775643B2 (en) 2004-08-12
DE60020873D1 (de) 2005-07-21
DE60020873T2 (de) 2006-05-04
GB9927629D0 (en) 2000-01-19
WO2001038288A1 (en) 2001-05-31
EP1232139A1 (de) 2002-08-21
CA2391953C (en) 2007-03-27
JP2003514886A (ja) 2003-04-22
GB2357083B (en) 2002-06-19

Similar Documents

Publication Publication Date Title
ATE297887T1 (de) Nervonsäurederivate,ihre herstellung und anwendung
CA2446944A1 (en) Anti-inflammatory and immunomodulatory amino acid derivatives, their preparation and use
ATE485258T1 (de) Glycyrrhetinsäurederivate und ihre verwendung zur herstellung eines medikaments zur hemmung der 11- beta-hydroxysteroid dehydrogenase
NO20056007L (no) Dobbel NK1/NK3 antagonister for behandling av schizofreni
WO2002100833A1 (fr) Inhibiteurs de rho kinase
CY1112800T1 (el) Η χρηση υποκαθιστουμενων κυανοπυρρολιδινων για τη θεραπεια της υπερλιπιδαιμιας
ATE374749T1 (de) Indol-derivate als antientzündungs wirkstoffe
MXPA04006322A (es) Derivados de 6-fluorobiciclo[3.1.0]hexano.
RS50140B (sr) Postupak za dobijanje perkihinina i njegova upotreba
BG108806A (en) IIb/IIIa CELL ADHESION INHIIBITORS, METHOD FOR THE PRODUCTION, PHARMACEUTCIAL COMPOSITION AND ADMINISTRATION THEREOF
EP1813270A4 (de) Proteininhibitoren der hsp90-familie
AP2002002637A0 (en) Novel piperazine
IL148426A0 (en) α-HYDROXY ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
DE69311837T2 (de) Steroide zur Behandlung von Prostatisch-Hypertrophe, ihre Herstellung und Verwendung
YU94103A (sh) Novi derivati sulfonske kiseline
NO20024241L (no) FremgangsmÕte for fremstilling av citalopram
HRP20041026A2 (en) Polycyclic compounds as potent alpha2-adrenoceptor antagonists
DK0453042T3 (da) Hidtil ukendte 2 9-disubstituerede 4H-pyhrido[1 2-a]pyridin-4-oner
YU30603A (sh) Derivati premošćenog piperazina
WO2003004497A1 (fr) Compose heterocyclique
ATE54910T1 (de) Substituierte tetrahydro-3-pyridincarbonsaeuren, ihre ester und amide als cholinergische mittel.
HUP0400545A2 (hu) Uro-szelektív alfa1-adrenoceptor gátlóanyagokként használatos 1,4-diszubsztituált piperazinszármazékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
DE60107832D1 (en) Chromenylmethylpyrimidindiamine als antibakterielle wirkstoffe
WO2004028455A3 (en) Monoacylated betulin and dihydrobetulin derivatives, preparation thereof and use thereof
CA2300289A1 (en) A pharmaceutical composition active in reducing production of mcp-1 protein

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1232139

Country of ref document: EP